aluminum sulfate has been researched along with Adverse Drug Event in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casella, CR; Mitchell, TC | 1 |
| Halperin, SA; Langley, JM; MacDonald, LD; MacKinnon-Cameron, D; McNeil, S; Saelens, X; Schepens, B; Stanford, MM; Weir, GM; Ye, L | 1 |
| Caubet, M; Nilsson, AC; Pascal, TG; Pauksens, K; Poolman, JT; Van Belle, P; Vandepapelière, PG; Verlant, V; Vink, PE | 1 |
| Aichinger, G; Aschoff, R; Barrett, PN; Crowe, BA; Dvorak, T; Esen, M; Jelinek, T; Kollaritsch, H; Kremsner, PG; Livey, I; Naudts, IF; O'Rourke, M; Pöllabauer, EM; Portsmouth, D; Schmitt, B; Schwendinger, MG; Weisser, R; Wressnigg, N; Zeitlinger, M | 1 |
| Firbas, C; Jilma, B | 1 |
| Brooks, WA; Chang, LJ; Hopfer, R; Sheng, X | 1 |
| Ellis, MW; Fahim, RE; Fattom, A; Fraser, J; Hospenthal, DR; Kessler, PD; Lalani, T; Landrum, ML; Maguire, JD; Niknian, M; Taylor, K; Tribble, DR; Wilkins, K | 1 |
| Ihara, T; Ishii, KJ; Kashiwagi, Y; Kawashima, H; Kumagai, T; Nakayama, T | 1 |
| Capron, A; Capron, M; Deplanque, D; Libersa, C; Martial, J; Remoué, F; Riveau, G; Schacht, AM; Thiry, M; Vodougnon, H | 1 |
2 review(s) available for aluminum sulfate and Adverse Drug Event
| Article | Year |
|---|---|
No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines.
Topics: Adjuvants, Immunologic; Alum Compounds; Antibodies, Viral; Diphtheria-Tetanus-acellular Pertussis Vaccines; Drug-Related Side Effects and Adverse Reactions; Humans; Lipid A; Pain; Papillomavirus Infections; Papillomavirus Vaccines; Toll-Like Receptor 4; Treatment Outcome; Vaccination; Whooping Cough | 2017 |
Product review on the JE vaccine IXIARO.
Topics: Adjuvants, Immunologic; Alum Compounds; Clinical Trials as Topic; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Encephalitis Virus, Japanese; Encephalitis, Japanese; Humans; Japanese Encephalitis Vaccines; Vaccines, Inactivated | 2015 |
6 trial(s) available for aluminum sulfate and Adverse Drug Event
| Article | Year |
|---|---|
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study.
Topics: Adjuvants, Immunologic; Alum Compounds; Antibodies, Viral; Drug-Related Side Effects and Adverse Reactions; Female; Healthy Volunteers; Humans; Immunity, Humoral; Immunization Schedule; Lipids; Male; Middle Aged; Placebos; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Respiratory Syncytial Virus, Human; Retroviridae Proteins, Oncogenic; Single-Blind Method; Vaccines, Subunit | 2018 |
Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adults.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Alum Compounds; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Opsonin Proteins; Phagocytosis; Placebos; Pneumococcal Vaccines; Saponins; Single-Blind Method; Streptolysins; Vaccines, Subunit | 2014 |
A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Alum Compounds; Antibodies, Bacterial; Antigens, Surface; Bacterial Outer Membrane Proteins; Bacterial Vaccines; Borrelia burgdorferi Group; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lipoproteins; Lyme Disease; Male; Middle Aged; Vaccination; Young Adult | 2014 |
Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: A phase I randomized controlled study.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alum Compounds; Antigens, Bacterial; Bacterial Proteins; Drug-Related Side Effects and Adverse Reactions; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infant; Male; Middle Aged; Placebos; Pneumococcal Vaccines; Single-Blind Method; Streptococcus pneumoniae; Vaccines, Subunit; Vaccines, Synthetic; Young Adult | 2015 |
Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alum Compounds; Antibodies, Bacterial; Antibodies, Neutralizing; Bacterial Toxins; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Exotoxins; Female; Healthy Volunteers; Hemolysin Proteins; Humans; Immunoglobulin G; Leukocidins; Male; Middle Aged; Placebos; Staphylococcal Infections; Staphylococcal Vaccines; Toxoids; Vaccines, Synthetic; Young Adult | 2017 |
Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alum Compounds; Animals; Antibodies, Helminth; Antigens, Helminth; Cytokines; Drug-Related Side Effects and Adverse Reactions; Glutathione Transferase; Healthy Volunteers; Helminth Proteins; Humans; Male; Neutralization Tests; Recombinant Proteins; Schistosoma haematobium; Schistosomiasis haematobia; Vaccination; Vaccines, Synthetic; Young Adult | 2012 |
1 other study(ies) available for aluminum sulfate and Adverse Drug Event
| Article | Year |
|---|---|
Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) enhanced inflammatory cytokine productions.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alum Compounds; Antibodies, Viral; Child; Child, Preschool; Cytokines; Drug-Related Side Effects and Adverse Reactions; Female; Fever; Humans; Infant; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Japan; Male; Middle Aged; Vaccines, Inactivated; Young Adult | 2012 |